Related Experiment Video
Updated: Jul 8, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Malondialdehyde-modified LDL as a marker of acute coronary syndromes
P Holvoet1, D Collen, F Van de Werf
1Center for Molecular and Vascular Biology, University of Leuven, Belgium. paul.holvoet@med.kuleuven.ac.be
Context:
Release of circulating malondialdehyde (MDA)-modified low-density lipoprotein (LDL) may reflect endothelial injury or plaque instability.
Objective:
To determine the usefulness of MDA-modified LDL for identifying patients with unstable angina and acute myocardial infarction (AMI).
Design:
Blinded comparison of MDA-modified LDL, C-reactive protein, and troponin I followed by multiple receiver operating curve analysis.
Setting:
University hospital.
Participants:
A total of 104 consecutive patients with acute coronary syndromes (42 with unstable angina and 62 with AMI), and 64 patients with stable coronary artery disease (CAD) without evidence of ischemia.
Main Outcome Measures:
Ability of MDA-modified LDL, C-reactive protein, and troponin I to discriminate patients with stable CAD, unstable angina, or AMI.
Results:
Malondialdehyde-modified LDL (chi2 = 10.2; P = .001), but not troponin I or C-reactive protein, discriminated between stable CAD and unstable angina. Troponin I (chi2 = 14.5; P<.001), but not MDA-modified LDL or C-reactive protein, discriminated between unstable angina and AMI. Both MDA-modified LDL and troponin I (chi2 = 14.5; P<.001 and chi2 = 5.3; P = .02, respectively) but not C-reactive protein discriminated between stable CAD and AMI. The sensitivity of MDA-modified LDL was 95% for unstable angina and 95% for AMI, with a specificity of 95%. Values for troponin I were 38% and 90%, respectively, with a specificity of 95%. The combination of MDA-modified LDL and troponin I had a sensitivity of 98% for unstable angina and 100% for AMI, with a specificity of 99%.
Conclusion:
The combination of MDA-modified LDL, which may reflect endothelial injury or plaque instability, and troponin I, which reflects myocardial cell injury, allows better discrimination between stable CAD and acute coronary syndromes than troponin I alone.
Insights
Malondialdehyde-modified LDL (MDA-LDL) effectively identifies unstable angina, while troponin I detects acute myocardial infarction (AMI). Combining MDA-LDL and troponin I improves diagnosis of acute coronary syndromes.
Area of Science:
- Cardiology
- Biochemistry
- Clinical Diagnostics
Background:
- Circulating malondialdehyde (MDA)-modified low-density lipoprotein (LDL) levels may indicate endothelial injury or plaque instability.
- Accurate identification of acute coronary syndromes (ACS) is crucial for timely intervention.
Purpose of the Study:
- To evaluate the diagnostic utility of MDA-modified LDL in identifying patients with unstable angina and acute myocardial infarction (AMI).
- To compare the discriminatory power of MDA-modified LDL, C-reactive protein, and troponin I in ACS.
Main Methods:
- A blinded comparative study involving 104 ACS patients and 64 stable coronary artery disease (CAD) patients.
- Receiver operating curve analysis was used to assess the ability of MDA-modified LDL, C-reactive protein, and troponin I to differentiate between stable CAD, unstable angina, and AMI.
Main Results:
- MDA-modified LDL distinguished between stable CAD and unstable angina (P = .001).
- Troponin I differentiated unstable angina from AMI (P<.001).
- Both MDA-modified LDL and troponin I identified stable CAD versus AMI (P<.001 and P = .02, respectively). The combination demonstrated high sensitivity (98% for unstable angina, 100% for AMI) and specificity (99%).
Conclusions:
- MDA-modified LDL shows promise in identifying endothelial injury and plaque instability in ACS.
- Combining MDA-modified LDL with troponin I enhances the discrimination between stable CAD and ACS, offering a more comprehensive diagnostic approach.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis I: Introduction

